Cambridge Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.07M Sell
27,297
-10,706
-28% -$1.99M 2.56% 25
2025
Q1
$7.96M Sell
38,003
-300
-0.8% -$62.9K 3.46% 15
2024
Q4
$6.81M Buy
+38,303
New +$6.81M 2.81% 24
2024
Q2
$6.17M Buy
35,981
+2,255
+7% +$387K 2.77% 27
2024
Q1
$6.14M Buy
33,726
+2,040
+6% +$371K 2.72% 27
2023
Q4
$4.91M Sell
31,686
-2,634
-8% -$408K 2.46% 28
2023
Q3
$5.12M Buy
+34,320
New +$5.12M 2.79% 24
2022
Q4
$5.09M Sell
31,488
-2,085
-6% -$337K 2.84% 22
2022
Q3
$4.51M Buy
+33,573
New +$4.51M 2.71% 23
2015
Q4
Sell
-90,488
Closed -$4.92M 32
2015
Q3
$4.92M Sell
90,488
-4,470
-5% -$243K 2.94% 25
2015
Q2
$6.38M Buy
94,958
+779
+0.8% +$52.3K 3.4% 15
2015
Q1
$5.51M Buy
94,179
+84,294
+853% +$4.93M 2.73% 30
2014
Q4
$647K Buy
+9,885
New +$647K 3.15% 24